Cost Of Illness Pengobatan Pasien Cronic Kidney Disease dengan Hemodialisa di Instalasi Rawat Jalan RS Soerojo Magelang
Cost of Illness Treatment for Chronic Kidney Disease Patients with Hemodialysis in the Outpatient Installation of Soerojo Hospital, Magelang
DOI:
https://doi.org/10.30872/Keywords:
Analisis Biaya, Biaya Medis, Chronic Kidney DiseaseAbstract
References
[1] M. Nisar et al., “The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review,” Cost Effectiveness and Resource Allocation, vol. 22, no. 1, p. 65, Sep. 2024, doi: 10.1186/s12962-024-00566-9.
[2] C. W. G. KDIGO, “KDIGO 2024 Clinical Practice Guideline for the Evaluastion and Management of Chronic Kideney Disease,” Kidney International, vol. 105, no. 4, p. A1, Apr. 2024, doi: 10.1016/S0085-2538(24)00110-8.
[3] N. M. Hustrini, “Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities,” Acta Medica Indonesiana, vol. 55, no. 1, pp. 1–1, Mar. 2023.
[4] S. Sari, Z. Suhada, and T. Triagustini, “Cost of illness pasien gagal ginjal kronis di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau,” Jurnal Ilmiah Farmasi, vol. 19, no. 2, pp. 113–125, Dec. 2023, doi: 10.20885/jif.vol19.iss2.art10.
[5] E. Sunariyanti, T. M. Andayani, D. Endarti, and D. A. Puspandari, “Cost Analysis of Chronic Kidney Disease Patients in Indonesia,” Clinicoecon Outcomes Res, vol. 15, pp. 621–629, 2023, doi: 10.2147/CEOR.S388547.
[6] Fauziah, D. Wahyono, and L. E. Budiarti, “Cost Of Illness Dari Chronic Kidney Disease Dengan Tindakan Hemodialisis,” Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), vol. 5, pp. 149–158, 2015.
[7] J. Mende, N. D. Kartikawati, A. Titami, and H. Mahmuda, “Principles Of Dose Adjustment In Patients With Chronic Kidney Failure,” Jurnal Farmasi Sains dan Praktis, pp. 115–126, 2025.
[8] I. Hadning, H. Hendrawan, and W. K. Rahayu, “Cost of illness of chronic kidney disease patients with hemodialysis in Yogyakarta Indonesia,” in AIP Conference Proceedings, AIP Publishing, 2024.
[9] A. R. Villanueva et al., “Cost-of-illness analysis of chronic kidney disease (CKD) management in the Philippines,” Journal of Medical Economics, vol. 28, no. 1, pp. 494–507, Dec. 2025, doi: 10.1080/13696998.2025.2481766.
[10] R. Andhika et al., “One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia,” Int J Nephrol Renovasc Dis, vol. 18, pp. 87–101, Mar. 2025, doi: 10.2147/IJNRD.S508012.
[11] R. Nindela, S. N. Prastowo, E. F. Zulissetiana, S. Marisdina, and S. S. F. Putri, “Impact of Age Initiation and Duration of Hemodialysis on Impaired Cognitive Function Experienced by Chronic Kidney Disease (CKD) Patients,” Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, vol. 18, no. 1, pp. 36–43, Jun. 2024, doi: 10.33533/jpm.v18i1.7830.
[12] M. Hecking et al., “Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study,” Kidney Int Rep, vol. 7, no. 3, pp. 410–423, Dec. 2021, doi: 10.1016/j.ekir.2021.11.018.
[13] N. D. Kartikawati, T. M. Andayani, and D. Endarti, “Gambaran dan Luaran Klinik Terapi Anemia Pada Pasien Chronic Kidney Disease Dengan Hemodialisis Di RS PKU Muhammadiyah Yogyakarta,” Majalah Farmaseutik, vol. 19, no. 1, pp. 148–154, 2023.
[14] S. R. Vaidya and N. R. Aeddula, Chronic Renal Failure. StatPearls Publishing, 2020. Accessed: Mar. 18, 2021. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK535404/
[15] D. T. Zainal, D. G. Tamtomo, and B. Murti, “Correlation between the Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis and Erythropoietin Stimulating Agent Therapy and Hemoglobin Levels,” Indonesian Journal of Medicine, vol. 9, no. 2, pp. 145-`155, Apr. 2024, doi: 10.26911/theijmed.2024.9.2.715.
[16] H. N. Murdeshwar and F. Anjum, “Hemodialysis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Sep. 02, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK563296/
[17] S. Tanaka, T. Nakano, H. Hiyamuta, K. Tsuruya, and T. Kitazono, “Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study,” J Atheroscler Thromb, vol. 29, no. 8, pp. 1249–1264, Aug. 2022, doi: 10.5551/jat.62900.
[18] C. MacRae, S. W. Mercer, B. Guthrie, and D. Henderson, “Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care,” Br J Gen Pract, vol. 71, no. 704, pp. e243–e249, Feb. 2021, doi: 10.3399/bjgp20X714125.
[19] C. Kyriakopoulos and V. Gupta, “Renal Failure Drug Dose Adjustments,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 28, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK560512/
[20] X. Liu, P. Chen, Y. Liu, X. Jia, and D. Xu, “Medication burden in patients with dialysis-dependent CKD: a systematic review,” Ren Fail, vol. 46, no. 1, p. 2353341, doi: 10.1080/0886022X.2024.2353341.
[21] H. Jyrkilä et al., “Comorbidity and Medication Trends in Chronic Kidney Disease and Incident Atrial Fibrillation: A Nationwide Cohort Study,” Nephron, vol. 148, no. 11–12, pp. 755–767, Jun. 2024, doi: 10.1159/000539603.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
How to Cite
Similar Articles
- Ana Amalia, Nurdiana Mufida Apriliani, Analisis Efektivitas Single Use dan Reuse Dialyzer pada Pasien Gagal Ginjal Kronik di RSUD Mardi Waluyo Kota Blitar , Jurnal Sains dan Kesehatan: Vol. 3 No. 5 (2021): J. Sains Kes.
- Alius Cahyadi, Maria Riastuti Iryaningrum, Christina Jeanny, Status Nutrisi pada Pasien Penyakit Ginjal Kronik yang Menjalani Hemodialisis dan Non-dialisis di RS Atma Jaya Tahun 2021-2024 , Jurnal Sains dan Kesehatan: Vol. 6 No. 3 (2025): J. Sains Kes.
- Ulyati Ulfah, Eli Halimah, Auliya A Suwantika , Analisis Efektivitas Biaya Pasien PROLANIS DM Tipe 2 di Puskesmas Kota Bandung , Jurnal Sains dan Kesehatan: Vol. 4 No. 1 (2022): J. Sains Kes.
- Masmudah, Hery Kurniawan, Yurika Sastyarina, Analisis Efektivitas Biaya (AEB) Pada Pasien Skizofrenia Di RSJD Atma Husada Mahakam Periode 2022 , Jurnal Sains dan Kesehatan: Vol. 7 No. 1 (2026): J. Sains Kes.
- Khoirunnisa Wal Hazimah, Mukti Priastomo, Rolan Rusli, Analisis Efektivitas Biaya Penggunaan Antibiotik pada Pasien Demam Tifoid di RS SMC Periode 2017 , Jurnal Sains dan Kesehatan: Vol. 2 No. 2 (2019): J. Sains Kes.
- Salva Dwi Kosayriyah, Vivin Nur Hafifah, Zainal Munir, Handono Fatkhur Rahman, Analisis Efektifitas Pursed Lip Breathing dan Balloon Blowing untuk Meningkatkan Saturasi Oksigen pada Pasien COPD (Chronic Obstructive Pulmonary Disease) , Jurnal Sains dan Kesehatan: Vol. 3 No. 2 (2021): J. Sains Kes.
- Imanuel Saputra Sembiring, Dewi Rahmawati, Adam M. Ramadhan, Analisis Efektivitas Biaya dan Minimal Biaya Pasien Diabetes Melitus Tipe 2 di RSUD Abdul Wahab Sjahranie Samarinda Tahun 2019 , Jurnal Sains dan Kesehatan: Vol. 4 No. 3 (2022): J. Sains Kes.
- Syefi Nuraeni Fitriana, Bambang Subakti Zulkarnain, Heri Yulimanida, Analisis Efek Samping Kanamisin dan Kapreomisin terhadap Fungsi Ginjal pada Pasien TB RO di RSUD Dr. Soetomo , Jurnal Sains dan Kesehatan: Vol. 5 No. 5 (2023): J. Sains Kes.
- Rani Nur Afifah, Muthia Dewi Marthilia Alim, Evaluasi Pola Pengobatan Coronavirus Disease 2019 (Covid-19) pada Ibu Hamil di Rumah Sakit Kota Samarinda , Jurnal Sains dan Kesehatan: Vol. 4 No. 6 (2022): J. Sains Kes.
- Sirilus Deodatus Sawu, Antonius Adji Prayitno, Yosi Irawati Wibowo, Analisis Faktor Risiko pada Kejadian Masuk Rumah Sakit Penyakit Jantung Koroner di Rumah Sakit Husada Utama Surabaya , Jurnal Sains dan Kesehatan: Vol. 4 No. 1 (2022): J. Sains Kes.
You may also start an advanced similarity search for this article.

